Karen Brown

1.8k total citations · 1 hit paper
20 papers, 1.3k citations indexed

About

Karen Brown is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Karen Brown has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 10 papers in Cardiology and Cardiovascular Medicine and 6 papers in Genetics. Recurrent topics in Karen Brown's work include Blood Coagulation and Thrombosis Mechanisms (14 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Karen Brown is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (14 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). Karen Brown collaborates with scholars based in United States, Switzerland and Norway. Karen Brown's co-authors include Jonathan M. Levenson, Mimi A. Trinh, J. David Sweatt, David L. Molfese, Kenneth J. O’Riordan, Valeria Chu, Robert J. Leadley, Dennis Colussi, Henry W. Pauls and Christopher T. Dunwiddie and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Medicinal Chemistry.

In The Last Decade

Karen Brown

20 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of Histone Acetylation during Memory Formation in the Hippocampus

2004 892 citations Jonathan M. Levenson, Kenneth J. O’Riordan et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen Brown United States	14	658	316	243	219	160	20	1.3k
Bagrat Abazyan United States	13	410 0.6×	113 0.4×	347 1.4×	53 0.2×	88 0.6×	13	988
Juan M. Luque Spain	22	557 0.8×	85 0.3×	727 3.0×	28 0.1×	90 0.6×	41	1.6k
Ioannis Parastatidis United States	13	418 0.6×	31 0.1×	156 0.6×	74 0.3×	42 0.3×	16	1.2k
Claude Walzer Switzerland	21	571 0.9×	79 0.3×	407 1.7×	35 0.2×	76 0.5×	42	1.2k
Kyoko Koshibu Switzerland	14	362 0.6×	151 0.5×	205 0.8×	11 0.1×	98 0.6×	29	794
Bernard Koch France	19	437 0.7×	148 0.5×	459 1.9×	32 0.1×	32 0.2×	73	1.4k
P. A. Slominsky Russia	20	609 0.9×	198 0.6×	377 1.6×	53 0.2×	69 0.4×	126	1.4k
Hussien Al‐Shamma United States	15	210 0.3×	83 0.3×	212 0.9×	47 0.2×	39 0.2×	20	814
Hui Qiao China	20	600 0.9×	151 0.5×	303 1.2×	19 0.1×	91 0.6×	56	1.5k
Thomas Bettecken Germany	22	786 1.2×	379 1.2×	163 0.7×	42 0.2×	204 1.3×	53	2.0k

Countries citing papers authored by Karen Brown

Since Specialization

Citations

This map shows the geographic impact of Karen Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Brown more than expected).

Fields of papers citing papers by Karen Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Brown. The network helps show where Karen Brown may publish in the future.

Co-authorship network of co-authors of Karen Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Brown. A scholar is included among the top collaborators of Karen Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Brown. Karen Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ansell, Jack, Sasha Bakhru, Bryan Laulicht, et al.. (2016). Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban. Thrombosis and Haemostasis. 117(2). 238–245. 104 indexed citations

Bakhru, Sasha, Bryan Laulicht, Xuan Jiang, et al.. (2013). Abstract 18809: PER977: A Synthetic Small Molecule Which Reverses Over-Dosage and Bleeding by the New Oral Anticoagulants. Circulation. 128(suppl_22). 31 indexed citations

Levenson, Jonathan M., Kenneth J. O’Riordan, Karen Brown, et al.. (2004). Regulation of Histone Acetylation during Memory Formation in the Hippocampus. Journal of Biological Chemistry. 279(39). 40545–40559. 892 indexed citations breakdown →

Guertin, Kevin R., Scott I. Klein, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity. Bioorganic & Medicinal Chemistry Letters. 12(12). 1671–1674. 45 indexed citations

He, Wei, Barbara Hanney, Michael R. Myers, et al.. (2002). Benzimidazoles and isosteric compounds as potent and selective factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(6). 919–922. 6 indexed citations

Klein, Scott I., Kevin R. Guertin, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 1: P4 and side-Chain modifications for improved In vitro potency. Bioorganic & Medicinal Chemistry Letters. 12(12). 1667–1670. 14 indexed citations

Rebello, Sam, Charles Kasiewski, Wei Wang, et al.. (2001). Role of Short-Term Inhibition of Factor Xa by FXV673 in Arterial Passivation: A Study in a Chronic Model of Thrombosis in Conscious Dogs. Journal of Cardiovascular Pharmacology. 38(2). 288–297. 9 indexed citations

Chu, Valeria, Karen Brown, Dennis Colussi, et al.. (2001). Pharmacological Characterization of a Novel Factor Xa Inhibitor, FXV673. Thrombosis Research. 103(4). 309–324. 23 indexed citations

Gong, Yong, Henry W. Pauls, Alfred P. Spada, et al.. (2000). Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa. Bioorganic & Medicinal Chemistry Letters. 10(3). 217–221. 9 indexed citations

10.

Heran, Christopher L., Charles Kasiewski, Jeffrey S. Bostwick, et al.. (2000). Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis. European Journal of Pharmacology. 389(2-3). 201–207. 23 indexed citations

11.

Gong, Yong, Michael R. Becker, Yong Mi Choi-Sledeski, et al.. (2000). Solid-phase parallel synthesis of azarene pyrrolidinones as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(10). 1033–1036. 13 indexed citations

12.

He, Wei, Barbara Hanney, Michael R. Myers, et al.. (2000). Nonbenzamidine compounds as selective factor xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(15). 1737–1739. 10 indexed citations

13.

Chu, Valeria, Karen Brown, Dennis Colussi, et al.. (2000). In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737. Thrombosis Research. 99(1). 71–82. 16 indexed citations

14.

Becker, Michael R., William R. Ewing, Henry W. Pauls, et al.. (1999). Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(18). 2753–2758. 19 indexed citations

15.

Leadley, Robert J., Ross Bentley, Jeffrey S. Bostwick, et al.. (1999). Pharmacodynamic Activity and Antithrombotic Efficacy of RPR120844, a Novel Inhibitor of Coagulation Factor Xa. Journal of Cardiovascular Pharmacology. 34(6). 791–799. 15 indexed citations

16.

Choi-Sledeski, Yong Mi, Michael R. Becker, William R. Ewing, et al.. (1999). Aminoisoquinolines: Design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA. Bioorganic & Medicinal Chemistry Letters. 9(17). 2539–2544. 20 indexed citations

17.

Bentley, Ross, Karen Brown, Valeria Chu, et al.. (1999). RPR120844, a Novel, Specific Inhibitor of Coagulation Factor Xa Inhibits Venous Thrombosis in the Rabbit. Thrombosis and Haemostasis. 81(1). 157–160. 16 indexed citations

18.

Klein, Scott I., Bruce F. Molino, Valeria Chu, et al.. (1998). Design of a New Class of Orally Active Fibrinogen Receptor Antagonists. Journal of Medicinal Chemistry. 41(14). 2492–2502. 15 indexed citations

19.

Klein, Scott I., Kevin R. Guertin, Daniel L. Cheney, et al.. (1998). Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa. Journal of Medicinal Chemistry. 41(4). 437–450. 35 indexed citations

20.

Pascall, John C., M. Azim Surani, S. C. Barton, Tristan J. Vaughan, & Karen Brown. (1994). Directed expression of simian virus 40 T-antigen in transgenic mice using the epidermal growth factor gene promoter. Journal of Molecular Endocrinology. 12(3). 313–325. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact